SOAT1 and lymphoma: Therefore, STAT inhibitors have been used in vitro and in animal models to suppress the proliferation of lymphoma cells, and antisense oligonucleotide drugs against STAT proteins have been used in phase 1 and 2 clinical trials against lymphomas with promising results 5.